Saturday, September 23, 2023
Saturday, September 23, 2023

What is Credo? Interview with CEO and Founder Carm Huntress Shares How Credo Will Change the Healthcare Industry

Credo is the leader in automated patient medical record retrieval. We’re working to radically simplify and update the current medical record and retrieval process, to support patients receiving better overall care.

How is Credo changing the healthcare industry?

The current medical record retrieval process is outdated and can result in incomplete patient health records. It’s time that the healthcare industry joins the digital revolution. Credo is leading the way at putting patients at the center of their care while empowering payers and providers with the vital data they need. I’m passionately focused on eradicating the manual processes that healthcare has relied on by eliminating the 15 billion faxed pages that are transmitted each year in the US.

What are some common pitfalls that prevent the successful transfer/release of patient records? Does it mainly have to do with losing physical copies of records without a digital backup?

Most pitfalls have to do with the high utilization of phone and fax to retrieve medical records.  Most providers lose track of requests or get overwhelmed with too many requests and can’t keep up. This has only become worse over the last two years due to staffing shortages.

How can Credo aid healthcare providers in ensuring patients can access their medical records?

Credo is a digital automated medical record retrieval solution that helps providers gain access to patients records while ensuring patients maintain access to their records moving forward.  We do this by using new digital on-ramps provided by the 21st Century Cures Act that enable direct digital access to patients medical records.

In what ways is Credo helpful to insurance providers?

We can help insurance providers by ending the practice of chart chasing to support risk adjustment for medicare advantage plans as well as the individual market under the ACA.

What features are included in the Credo interface? How do they differ based on user (i.e. healthcare provider, patient, or insurance provider)?

Our system works universally across all users as it takes requests to get the records for a particular patient or member of a health plan and then our team supports them through the process of gaining access to their historical medical record data and then we ensure it’s sent to the right provider or payer so they can better treat that patient with their complete medical record.

Can you explain Credo’s pricing/what it means for pricing to be “based on success, not pages”?

We charge our customers a one time flat fee only if we’re able to retrieve the records for an individual patient. If for some reason we can’t retrieve the records we don’t get paid.

Can you explain the state guidelines pertaining to how long a health care provider must maintain patient records?

This all depends on state regulations and most states require providers to hold onto records anywhere from 3 to 10 plus years.

How can healthcare providers find out more about Credo’s product, and when will the official product rollout take place?

Editor’s Note: Credo is the leader in automated patient medical record retrieval. Credo is working to radically simplify and update the current medical record and retrieval process, to support patients receiving better overall care. Credo’s innovative digital solution offers healthcare providers and payers with an alternative to traditional faxed based processes that can result in incomplete patient health records with costly mistakes.

Carm Huntress is the founder and CEO of Credo, the leader in automated patient medical record retrieval. Carm is a nationally recognized digital health leader actively building and scaling healthcare technology. His first company RxRevu raised over $35m in venture capital, scaling to the largest national network for real time cost transparency for providers. The RxRevu network now supports over 250,000 providers across 700 hospitals, offering real time pricing for over 150 million insured Americans. 

Following RxRevu’s success, Carm is focused on his latest venture, Credo, to radically simplify and update the current medical record and retrieval process. Credo’s digital solution offers healthcare providers with an alternative to traditional faxed based processes that result in incomplete patient health records with costly mistakes. Through Credo, Carm is passionately working to eradicate the manual processes healthcare has relied on for years.

At a national level, Carm has been instrumental in supporting interoperability and patient access to data through demonstration projects supported by the Office of National Coordinator (ONC) and the development of the Fast Healthcare Interoperability Resource (FHIR). 

Carm is a passionate thought leader, presenting at dozens of healthcare innovation conferences and summits, and has been featured on CNBC. He currently lives in Denver with his two sons and enjoys the outdoors.

To learn more about Credo and to request a demonstration, visit their website at www.credohealth.com request a demo.

 

Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Lipogems® Announces 140 Independent Peer Reviewed Publications with 5 Years of Follow up in Orthopaedics

Giorgio Ninzoli, President of Lipogems International. "The gold standard for evidence is 1 year follow up and we are excited to report 5 years follow up with positive results after a single injection of MicroFat."

Stryker’s Triathlon Tritanium Baseplate Marks a Decade of Positive Patient Impact

Marking its 10th anniversary, the Triathlon Tritanium baseplate is designed with Stryker Orthopaedic Modeling and Analytics (SOMA) and enabled by Stryker's proprietary additive manufacturing technology.

Medtronic Diabetes Announces CE Mark for New Simplera™ CGM with Disposable All-in-one Design

The company's newest Simplera™ CGM is 50% smaller than its previous generation with a simple insertion and improved user experience

Study Outcomes Could Provide Insights Into New Targeted Treatments to Manage this Challenging Disease

The study aims to determine if immediate biological preservation of patient-derived chordoma tumor tissue, collected intraoperatively and implanted for serial sampling in translational research, will provide new insights into the biological weakness of the disease and contribute to developing improved treatment therapies reports NICO.

Henkel Joins with MedTech Europe to Drive Innovation In the Medical Technology Industry

Henkel has a long history of supporting the medical technology industry with its advanced adhesive and surface solutions. Through this, Henkel and MedTech Europe will collaborate on various initiatives such as supporting research and development projects, driving thought leadership and engaging in industry forums.

By using this website you agree to accept Medical Device News Magazine Privacy Policy